AI-generated summary
The authors retrospectively reviewed 25 Chinese patients with melasma treated with a low-fluence 730-nm picosecond laser alone. Mean Melasma Area and Severity Index scores fell by 33.7% over an average follow-up of 8.48 weeks, and no hyper- or hypopigmentation was observed. The authors conclude the laser was effective and safe, though the study was retrospective with a small sample.
- Participants
- 25
- Who or what was studied
- Chinese patients with Fitzpatrick skin types II to IV and melasma treated at a clinic between April 2021 and April 2022
- Wavelengths
- 730 nm
- Limits stated in the abstract
- The study was a small retrospective review of 25 patients with no control group, and efficacy was assessed from photographs scored by blinded dermatologists.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.